CHRNA4 and Alzheimer disease: These concentrations of memantine in extracellular brain compartment and brain tissue are expected to significantly inhibit nAChR-mediated neurogenic vasodilation (Figure 1), suggesting the possibility of worsening the already decreased regional cerebral blood flow in AD patients and accelerating the pathological progress [19], [20].